Clinical trial
Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment
NCT00083967 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00083967 |
|---|---|
| Title | Study of Denufosol (INS37217) in Subjects With Rhegmatogenous Retinal Detachment |
| Official title | A Randomized, Double-Masked, Placebo Controlled, Parallel Group, Multi-Center, Dose-Ranging Study of Denufosol Tetrasodium (INS37217) Intravitreal Injection in Subjects With Rhegmatogenous Retinal Detachment |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Retinal Detachment |
| Intervention type | Drug |
| Interventions | denufosol tetrasodium (INS37217) Intravitreal Injection |
| Enrollment | 23 |
| Start date | Jun 1, 2004 |
| Primary completion | Apr 1, 2006 |
| Completion | Apr 1, 2006 |
| First posted | Jun 7, 2004 |
| Last update posted | Apr 10, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: